catalyst

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia — primary completion

as of 2026-07-01
at a glance
2020-05-06 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia — primary completion
Type
Trial Readout
Date
2020-05-06
Date type
ACTUAL
Phase
Phase 3
This event happened.